Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fluoxetine (prozac) (1 trial)
naltrexone (revia) (1 trial)
olanzapine (zyprexa) (1 trial)
zonisamide (Zonegran) (1 trial)
Compulsive Personality Disorder (Phase 2)
Disease (Phase 2)
Obsessive-Compulsive Disorder (Phase 2)
Psychotic Disorders (Phase 2)
Schizophrenia (Phase 2)
Weight Gain (Phase 2)
Trials (2 total)
Trial APIs (4 total)